IDEXX Laboratories, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $180.1M | $288.3M | $453.9M | $112.5M | $144.5M | $383.9M | $90.3M | $123.8M |
| Accounts Receivable | $552.4M | $473.6M | $457.4M | $400.6M | $368.3M | $331.4M | $269.3M | $248.9M |
| Inventory | $377.8M | $381.9M | $380.3M | $367.8M | $269.0M | $209.9M | $195.0M | $173.3M |
| Total Current Assets | $1.41B | $1.40B | $1.50B | $1.10B | $955.7M | $1.06B | $679.6M | $654.2M |
| Property, Plant & Equipment | $747.4M | $713.1M | $702.2M | $649.5M | $587.7M | $555.2M | $533.8M | $437.3M |
| Goodwill | $414.0M | $405.1M | $366.0M | $361.8M | $359.3M | $243.3M | $239.7M | $214.5M |
| Intangible Assets (Excl. Goodwill) | $109.8M | $111.7M | $84.5M | $97.7M | $99.0M | $52.5M | $58.5M | $41.8M |
| Total Assets | $3.35B | $3.29B | $3.26B | $2.75B | $2.44B | $2.29B | $1.83B | $1.54B |
| Liabilities | ||||||||
| Accounts Payable | $110.4M | $114.2M | $110.6M | $110.2M | $116.1M | $74.6M | $72.2M | $69.5M |
| Total Current Liabilities | $1.15B | $1.07B | $951.5M | $1.24B | $763.6M | $582.8M | $725.3M | $770.4M |
| Long-Term Debt | $374.8M | $449.8M | $622.9M | $694.4M | $775.2M | $858.5M | $698.9M | $601.8M |
| Total Liabilities | $1.75B | $1.70B | $1.78B | $2.14B | $1.75B | $1.66B | $1.65B | $1.55B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $6.39B | $5.33B | $4.44B | $3.60B | $2.92B | $2.18B | $1.60B | $1.17B |
| Total Stockholders' Equity | $1.61B | $1.60B | $1.48B | $608.7M | $690.0M | $632.1M | $177.5M | $-9.5M |